Prognostic significance of baseline thyroid variables in IDH-wildtype glioblastoma patients treated with regorafenib.
作者信息
Lawson McLean Aaron
机构信息
Department of Neurosurgery, Jena University Hospital - Friedrich Schiller University Jena, Am Klinikum 1, 07747, Jena, Germany.
出版信息
J Neurooncol. 2023 Aug;164(1):267-268. doi: 10.1007/s11060-023-04408-1. Epub 2023 Aug 10.
Abstract
摘要
相似文献
1
Prognostic significance of baseline thyroid variables in IDH-wildtype glioblastoma patients treated with regorafenib.基线甲状腺变量在接受瑞戈非尼治疗的异柠檬酸脱氢酶野生型胶质母细胞瘤患者中的预后意义。
J Neurooncol. 2023 Aug;164(1):267-268. doi: 10.1007/s11060-023-04408-1. Epub 2023 Aug 10.
2
Targeted anticonvulsive treatment of IDH-wildtype glioblastoma based on DNA methylation subclasses.基于DNA甲基化亚类的异柠檬酸脱氢酶野生型胶质母细胞瘤的靶向抗惊厥治疗
Neuro Oncol. 2023 May 4;25(5):1006-1008. doi: 10.1093/neuonc/noad014.
3
Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study.甲状腺功能与复发野生型 IDH 胶质母细胞瘤患者regorafenib 疗效的相关性：一项大型多中心研究。
J Neurooncol. 2023 Jun;163(2):377-383. doi: 10.1007/s11060-023-04356-w. Epub 2023 Jun 1.
4
Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma.复发性胶质母细胞瘤患者应用regorafenib 治疗的临床和 NGS 预测因子。
Sci Rep. 2022 Sep 28;12(1):16265. doi: 10.1038/s41598-022-20417-y.
5
O-methylguanine-DNA methyltransferase promoter methylation and isocitrate dehydrogenase mutation as prognostic factors in a cohort of Saudi patients with glioblastoma.O-甲基鸟嘌呤-DNA甲基转移酶启动子甲基化和异柠檬酸脱氢酶突变作为沙特胶质母细胞瘤患者队列中的预后因素。
Ann Saudi Med. 2019 Nov-Dec;39(6):410-416. doi: 10.5144/0256-4947.2019.410. Epub 2019 Dec 5.
6
Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH-wildtype glioblastoma.CDKN2A 纯合缺失联合甲基化 MGMT 状态对 IDH 野生型胶质母细胞瘤的临床意义。
Cancer Med. 2021 May;10(10):3177-3187. doi: 10.1002/cam4.3860. Epub 2021 Apr 10.
7
Predictive value of MGMT promoter methylation on the survival of TMZ treated -mutant glioblastoma.MGMT 启动子甲基化对替莫唑胺治疗的突变型胶质母细胞瘤患者生存的预测价值。
Cancer Biol Med. 2021 Feb 15;18(1):272-282. doi: 10.20892/j.issn.2095-3941.2020.0179.
8
Partial resection offers an overall survival benefit over biopsy in MGMT-unmethylated IDH-wildtype glioblastoma patients.在未甲基化 MGMT 伴 IDH 野生型胶质母细胞瘤患者中，部分切除术比活检提供了整体生存获益。
Surg Oncol. 2020 Dec;35:515-519. doi: 10.1016/j.suronc.2020.10.016. Epub 2020 Nov 1.
9
Updates in IDH-Wildtype Glioblastoma.IDH 野生型胶质母细胞瘤的最新进展。
Neurotherapeutics. 2022 Oct;19(6):1705-1723. doi: 10.1007/s13311-022-01251-6. Epub 2022 May 31.
10
Differentiating between glioblastomas with and without isocitrate dehydrogenase gene mutation by findings on conventional magnetic resonance images.通过常规磁共振成像表现鉴别伴有和不伴有异柠檬酸脱氢酶基因突变的胶质母细胞瘤。
J Clin Neurosci. 2020 Jun;76:140-144. doi: 10.1016/j.jocn.2020.04.016. Epub 2020 Apr 11.
本文引用的文献
1
Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study.甲状腺功能与复发野生型 IDH 胶质母细胞瘤患者regorafenib 疗效的相关性：一项大型多中心研究。
J Neurooncol. 2023 Jun;163(2):377-383. doi: 10.1007/s11060-023-04356-w. Epub 2023 Jun 1.
2
Molecular Functions of Thyroid Hormone Signaling in Regulation of Cancer Progression and Anti-Apoptosis.甲状腺激素信号在调控癌症进展和抗细胞凋亡中的分子功能。
Int J Mol Sci. 2019 Oct 9;20(20):4986. doi: 10.3390/ijms20204986.
3
Health status, mood, and cognition in experimentally induced subclinical hypothyroidism.实验性诱导亚临床甲状腺功能减退症中的健康状况、情绪和认知
J Clin Endocrinol Metab. 2007 Jul;92(7):2545-51. doi: 10.1210/jc.2007-0011. Epub 2007 May 1.
Zotero 插件